Annual Drug Patent Expirations for QELBREE
Qelbree is a drug marketed by Supernus Pharms and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has nineteen patent family members in seven countries.
The generic ingredient in QELBREE is viloxazine hydrochloride. One supplier is listed for this compound. Additional details are available on the viloxazine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
